The Moses H. Cone Memorial Hospital, also known as Moses Cone Hospital, is a 517-bed tertiary care facility located in Greensboro, North Carolina. The hospital opened in 1953 on North Elm Street as a 310-bed community hospital.

There are 517 beds in Moses H Cone Memorial Hospital.

During the past decade, Moses H Cone Memorial Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 15 clinical trials were completed, i.e. on average, 68.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Moses H Cone Memorial Hospital" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 13 trials, followed by "AIDS Clinical Trials Group" with 6 trials sponsored, "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials sponsored, "Abbott Medical Devices" with 4 trials sponsored and "Amgen" with 4 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Moses H Cone Memorial Hospital" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 6 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 3 trials as a collaborator, "Glaxo Wellcome" with 2 trials as a collaborator and "Adult AIDS Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Moses H Cone Memorial Hospital" are "HIV Infections" (16 trials), "HIV-1 Infection" (3 trials), "Ischemic Stroke" (3 trials), "Respiratory Distress Syndrome, Adult" (3 trials) and "Stroke" (3 trials). Many other conditions were trialed in "Moses H Cone Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Moses H Cone Memorial Hospital" are "Drug" (40 trials), "Device" (13 trials), "Other" (7 trials), "Procedure" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Indinavir sulfate" (7 trials), "Zidovudine" (7 trials), "Efavirenz" (5 trials) and "Lamivudine" (5 trials). Other intervention names were less common.

The vast majority of trials in "Moses H Cone Memorial Hospital" are 64 trials for "All" genders.

Currently, there are NaN active trials in "Moses H Cone Memorial Hospital". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Moses H Cone Memorial Hospital, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Moses H Cone Memorial Hospital, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".